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Abstract 
Currently, there is a large interest in the labeling of neural stem cells (NSCs) with iron oxide 
nanoparticles (IONPs) to allow MRI-guided detection after transplantation in regenerative 
medicine. For such biomedical applications, excluding nanotoxicity is key. Nanosafety is 
primarily evaluated in vitro where an immortalized or cancer cell line of murine origin is 
often applied, which is not necessarily an ideal cell model. Previous work revealed clear 
neurotoxic effects of PMA-coated IONPs in distinct cell types that could potentially be 
applied for nanosafety studies regarding neural cell labeling. Here, we aimed to assess if 
DMSA-coated IONPs could be regarded as a safer alternative for this purpose and how the 
cell model impacted our nanosafety optimization study. Hereto, we evaluated cytotoxicity, 
ROS production, calcium levels, mitochondrial homeostasis and cell morphology in six 
related neural cell types, namely neural stem cells, an immortalized cell line and a cancer cell 
line from human and murine origin. The cell lines mostly showed similar responses to both 
IONPs, which were frequently more pronounced for the PMA-IONPs. Of note, ROS and 
calcium levels showed opposite trends in the human and murine NSCs, indicating the 
importance of the species. Indeed, the human cell models were overall more sensitive than 
their murine counterpart. Despite the clear cell type-specific nanotoxicity profiles, our 
multiparametric approach revealed that the DMSA-IONPs outperformed the PMA-IONPs in 
terms of biocompatibility in each cell type. However, major cell type-dependent variations in 
the observed effects additionally warrant the use of relevant human cell models.  
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Introduction 
Nanotechnology yields numerous nanomaterials with interesting properties, which can be 
exploited in a plethora of possible applications. The biomedical field, for instance, aims to 
apply these materials to develop novel or improve existing diagnostic and/or therapeutic 
strategies.[1-4] 
A category of inorganic nanoparticles (NPs) for biomedical use that has received much 
attention over the last two decades, are iron oxide (IO)NPs.[5] By creating nanosized iron 
oxide particles, the material acquires superparamagnetic properties, which allows its 
implementation in biomarker and pathogen detection assays[6-8], protein sequestration[8], 
cell sorting[9], drug delivery[10] and cancer treatment through hyperthermia.[5, 11] 
Importantly, IONPs can also be applied as contrast agents for magnetic resonance imaging 
(MRI).[12, 13] In this regard, FDA-approved dextran-coated IONPs (USA: Feridex®, EU: 
Endorem®) have been clinically applied for the MRI-guided detection of liver lesions and 
tumors, before the production was discontinued in 2009.[14, 15] This MRI susceptibility can 
furthermore be exploited for regenerative cell therapy, where stem cells are transplanted 
into damaged tissues to replace the latter or promote cell survival and tissue repair via the 
secretion of specific factors.[16, 17] To monitor the cell distribution and engraftment, such 
therapies require a non-invasive method to track the transplanted cells in vivo, which can be 
accomplished by ex vivo cell labeling prior to the transplantation.[16, 18] 
In the context of regenerative medicine, there is a large interest in IONP labeling of neural 
stem cells before transplantation into the neural trauma site.[17, 19, 20] Since IONP with a 
diameter below 10 nm are typically applied for this purpose, we synthesized IONPs with a 
core diameter of ˜4 nm.[21] Overall, cell survival is an inherent drawback to this therapeutic 
modality and IONPs should persist inside the cells to allow long-term cell tracking, they may 
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not negatively affect cellular homeostasis.[18] Hence, IONP optimization in terms of 
nanosafety is of key importance. Previous work from our group on IONPs coated with 
poly(isobutylene-alt-maleic anhydride) grafted with dodecylamine (PMA) showed a 
disturbed cellular homeostasis at sublethal doses, making this construct less ideal for the 
labeling of neural cells.[22] Coating with the ligand 2,3-meso-dimercaptosuccinic acid 
(DMSA) could be a valuable alternative to improve the nanosafety profile. Indeed, DMSA is 
an FDA-approved chelator applied in case of lead intoxication and DMSA-IONPs show good 
biocompatibility both to neural cells in vitro and neural tissue in vivo.[23-25] 
In general, many hazard identification studies are initially performed in vitro applying cell 
lines given their easy accessibility and applicability.[26-29] However, we and other groups 
have demonstrated that primary cells or stem cells often respond differently to NP exposure 
as compared to the cell line counterpart.[22, 30-32] In addition, murine cell types are 
regularly applied despite reported species-related variations in NP-induced effects, which 
impede the extrapolation of results towards possible human scenarios.[33-35] Although 
several groups investigated either the species or cell type associated diversity in NP-evoked 
responses,[36-38] such studies remain rare for neural cell types. Previous work from our 
group revealed cell type specific neurotoxicity profiles in response to PMA-IONPs.[22] Given 
the clear perturbation of cell homeostasis, the PMA-IONPs were considered less fit for 
neural stem cell labeling in the context of regenerative medicine. Hence, we set out to 
optimize the IONPs by applying a different coating. To investigate whether the cell type 
equally impacts nanosafety optimization studies we compared the nanosafety profile of 
DMSA-coated IONPs to the previously applied PMA-IONPs. Please note that the same PMA-
IONP sample was applied as described in our previous work.[22] In short, we evaluated the 
cellular responses in neural cell types that could possibly be selected as an in vitro model for 
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neural stem cell labeling prior to transplantation in regenerative medicine, namely neural 
stem cells (NSCs), a neural immortalized (progenitor) cell line and neuroblastoma 
(cancerous) cell line from both humans and mice.[26-28] This setup will allow us to rationally 
guide the cell type selection for future nanosafety studies in the context of biomedical 
applications.  
 
Materials & methods 
1. IONP synthesis and characterization 
IONPs were synthesized and coated with either the meso-2,3-dimercaptosuccinic acid 
(DMSA) ligand or the polymer poly(isobutylene-alt-maleic anhydride) grafted with 
dodecylamine (PMA) according to established protocols previously applied by our group.[22, 
25, 39-41] Following synthesis, the core diameter was measured using transmission electron 
microscopy (TEM, Jeol JEM3010). UV/VIS absorption spectroscopy (Agilent 8453 UV-visible 
Spectroscopy System) was applied to evaluate the spectral characteristics, and the 
concentrations of the dispersions were determined via UV/VIS absorption spectroscopy and 
inductively coupled plasma mass spectrometry (ICP-MS, 7700 Series ICP-MS from Agilent 
Technologies). Finally, the hydrodynamic diameter and zeta-potential were measured using 
a Zetasizer Nano ZS (Malvern Instruments). Detailed information on the synthesis and 
characterization procedures is provided in the Supplementary Information.  
 
2. Cell culture 
The human NSCs (hNSCs [42]) were purchased from Invitrogen (Belgium). Both the murine 
NSCs (mNSCs [42]) and human progenitor cell line (ReNcell VM [43]) were obtained from 
Millipore (Belgium). Sigma (Belgium) provided the murine progenitor (C17.2 [44]) and 
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neuroblastoma (Neuro-2a [45]) cell line. Finally, the human neuroblastoma cell line (LA-N-2 
[46]) was retrieved through the European Collection of Cell Cultures. 
All cell types were cultured according to the manufacturers guidelines and kept at 37 °C in a 
humidified atmosphere completed with 5% CO2. Every other day, cells received fresh cell 
medium until 80% confluence was reached and the cells were passaged. Hereto, the cells 
were detached using 0.05% trypsin–EDTA (Invitrogen, Belgium), centrifuged 4 minutes at 
300 g and seeded at appropriate densities. Experiments were performed on cells with a 
passage number below 20. Detailed cell culture protocols are provided in the Supplementary 
Information.  
 
3. Cytotoxicity 
Cells were seeded in opaque 96-well plates at a density of 25000 cells/well and were allowed 
to settle overnight. The subsequent 24 hours, cells were exposed to 3.5, 7, 14, 35, 70 and 
140 nM IONP dispersions. Subsequently, the CellTiter-GLO® assay (Promega, Belgium) was 
performed according to the manufacturer’s instructions. Hereto, 100 µL of the assay buffer 
was added to each sample, plates were shaken during 2 minutes and following a 10-minute 
incubation, the signal was measured using a GloMax® 96 Luminometer (Promega, Belgium). 
 
4. ROS and intracellular free calcium  
Cells were seeded in 24-well plates at appropriate densities (Supplementary Information). 
The cells were allowed to settle overnight before being exposed to 7, 14, 35, 70 or 140 nM 
IONP dispersions for 24 hours. Notably, since the applied NP dispersion volume was adjusted 
according to the cell density, the NP number/volume cell medium/cell number remained 
equal in all experiments (Table S1).  
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After discarding the IONP containing medium, the cells were labelled with CellROX® green 
and Rhodamine-2 AM (Molecular Probes, Belgium) to allow visualization of reactive oxygen 
species (ROS) and free calcium present in the cytosol, respectively. Both were detected using 
the IN Cell analyser 2000 (GE Healthcare Life Sciences, Belgium) and the acquired data were 
analysed using in house developed protocols with the IN Cell Developer Toolbox software 
(GE Healthcare Life Sciences, Belgium). Detailed staining and analysis protocols are provided 
in the Supplementary Information.  
 
5. Mitochondria and cell morphology 
Cells were seeded at appropriate densities as described in the previous paragraph. The cells 
were allowed to settle overnight and were subsequently exposed to 3.5, 7, 14, 35 and 70 nM 
IONP dispersions. After a 24-hour incubation period, the NP dispersions were discarded and 
the mitochondria and cell cytoplasm were respectively labelled with Mitotracker® CMX-ROS 
Red and HCS CellMask™ Blue (both Molecular Probes, Belgium). Data were obtained with the 
IN Cell Analyzer 2000 and analysed with the IN Cell Developer Toolbox software. Detailed 
information on the staining procedure, data acquisition and data analysis is provided in the 
Supplementary Information.  
 
6. Statistics 
Cytotoxicity data are expressed as the mean ± standard error of the mean (SEM, n=3). IN Cell 
data are presented as the mean normalized against the untreated control ± SEM for two 
independent replicates, with a minimum of 10000 cells being analysed per replicate. 
Statistical analysis was performed using the 6th version of the GraphPad Prism software. 
Treated samples were compared with the untreated control by means of one-way ANOVA 
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combined with the post-hoc Dunnett test. Additionally, responses induced by the differently 
coated IONPs were compared with two-way ANOVA followed by the Bonferroni post-hoc 
test.  
 
Results  
1. IONP characterization 
The core diameter (dc) of the synthesized IONPs was quantified with transmission electron 
microscopy (TEM), which showed a mean value of 3.8 nm (Figure 1c & 1d). Next, the IONPs 
were coated with a ligand or polymer, respectively meso-2,3-dimercaptosuccinic acid 
(DMSA, Figure 1a) and poly-(isobutylene-alt-maleic) anhydride grafted with dodecylamine 
(PMA, Figure 1b).[22] As measured with dynamic light scattering, the hydrodynamic 
diameter in number distribution (dh) was 11.83 ± 0.61 and 12.33 ± 0.75 nm with a 
polydispersity index of 0.185 and 0.308 for the DMSA- and PMA-coated IONPs, respectively. 
In addition, both IONPs showed a strong, negative charge of -55.5 ± 0.9 mV for the IONP-
DMSA and -54 ± 2.2 mV for the IONP-PMA.[22] Further characterization in terms of the 
absorption spectra, molecular extinction coefficient, initial NP dispersion concentration and 
electrophoretic mobility is provided in the Supplementary Information (Tables S2 and S3, 
Figures S4 and S5). 
 
2. Cytotoxicity 
In a first set of cell-based experiments we evaluated the IONP-induced cell injury. Upon 
exposure to higher doses, several cell types experienced cell damage, which was most 
pronounced in the hNSCs (Figure 2). In contrast, the murine Neuro-2a neuroblastoma cell 
line was most resilient to IONP exposure, as only the highest dose of PMA-IONPs evoked a 
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minor, though significant, effect. In the majority of the cell types (the hNSCs, mNSCs and the 
murine C17.2 and Neuro-2a cell lines), the PMA-IONPs induced more severe effects than the 
DMSA-IONPs. However, in the ReNcell and LA-N-2 cell line, the opposite was true. Finally, 
when comparing the human cell types to their murine counterpart, the former appeared to 
be more sensitive, irrespective of the coating. 
 
3. ROS production 
To assess whether IONP exposure could affect the cell homeostasis at sublethal doses, we 
first looked into the effect of ROS production via staining with the CellROX® green probe.[47] 
This is especially important in neural cells since (i) ROS is a key player in the initiation and 
progression of several neurodegenerative disorders and (ii) neural cells are especially 
sensitive to oxidative stress given their high metabolic rate and low anti-oxidative 
capacity.[48] Three responses could be distinguished; an increase, a decline or a steady state 
(Figure 3). In case of the first two responses, the induced effects were IONP-concentration 
dependent. Similar to the cell damage, the observed changes in ROS levels were most 
pronounced in the NSCs. For instance, in the hNSCs the DMSA-coated IONPs evoked a three-
fold ROS induction at the highest concentration tested, whereas a decline was induced by 
the IONP-PMA. Notably, exact opposite trends were obtained in the mNSCs, indicating 
species-specific effects. Likewise, in the human progenitor cell line (ReNcell), both IONPs 
caused ROS induction whereas a decline was seen in the murine counterpart (C17.2). In 
contrast, in both neuroblastoma cell lines only the PMA-coated IONPs significantly reduced 
ROS. Overall, the PMA-IONPs evoked more severe effects in the included cell lines but no 
general statements can be made on the interspecies variations.  
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4. Cytoplasmic calcium signal 
Next, we evaluated the Ca2+ homeostasis in terms of the cytosolic free calcium concentration 
([Ca2+]c) through Rhodamine-2 AM staining.[47] The latter is an important indicator of cell 
function, especially in neural cells, given its involvement in numerous intracellular processes 
(metabolic activity, gene expression, neurotransmitter release, cell proliferation and cell 
death, etc.).[49-52] Similar to the results on ROS production, we found either a 
concentration dependent decline or augmentation in [Ca2+]c or no significant changes (Figure 
4). In both NSCs and the C17.2 cell line, the differentially coated IONPs induced opposite 
effects. Where the PMA-IONPs caused an elevated [Ca2+]c in the hNSCs and C17.2 cells, a 
significant decrease was noted for the DMSA-IONPs. Again, the opposite was true for the 
mNSCs. In the human progenitor cell line (ReNcell), Ca2+-levels were significantly elevated by 
both IONPs and the PMA-IONPs, which once more evoked stronger responses. In the murine 
Neuro-2a cell line, both IONPs induced a significant decline, which was significantly greater 
for the IONP-DMSA. In the LA-N-2 cell line this response was only observed for the PMA-
IONPs, as the DMSA-IONPs did not induce a significant effect. Here, less pronounced 
responses were detected in the murine NSCs and C17.2 cell line compared to their human 
counterparts. 
 
5. Mitochondrial homeostasis 
In turn, the mitochondria provide the bulk of the cellular energy, require Ca2+ signaling for 
their function, produce significant amounts of ROS and are associated with programmed cell 
death.[53, 54] In addition, the ΔΨm is a known effector in neurodegenerative disorders.[55] 
When the ΔΨm is compromised, the mitochondria fail to produce ATP and cytochrome C can 
be released, followed by the initiation of apoptosis.[53, 56] These organelles were labeled 
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with Mitotracker® CMX-ROS Red, which accumulates in the organelle based on the 
mitochondrial membrane potential (ΔΨm). When the ΔΨm is compromised due to NPs directly 
interacting with the mitochondrial membrane or ROS-induced membrane damage, the dye 
can no longer accumulate and the mitochondrial signal area relative to the total cell area 
decreases.[57] Figure 5 shows the relative signal area to be reduced or unaffected by IONP 
exposure. The latter was true for both IONPs in the Neuro-2a cell line and the C17.2 cells 
exposed to DMSA-IONPs. In all other cases the IONPs significantly reduced the ΔΨm. Notably, 
the ReNcells were most severely affected by both IONPs, followed by the hNSCs. Similar to 
the cytotoxicity observations, the human cell types were more sensitive to IONP exposure 
than the murine counterparts. On the whole, the onset of the effect occurred at lower doses 
for the IONP-PMA and effects were significantly more severe as compared to the DMSA-
IONPs, except in the LA-N-2 neuroblastoma cells where no significant differences were 
detected between both IONPs.  
 
6. Cell morphology 
Following cell labeling with HCS CellMask™ Blue, cell morphology was evaluated in terms of 
cell area and cell circularity.[22] The latter is defined as a value between zero and one, with 
one representing a perfect sphere. Thus, a lower value corresponds to a more complex cell 
morphology whereas an increase due to IONP exposure points to cell rounding and loss of 
specific morphological features, such as neurite outgrowths.[22] Cell morphology is a 
convenient parameter to include in a multiparametric analysis, as cell death has specific 
morphological features whereas minor alterations to cytoskeleton building blocks can impair 
cell functions that require signaling via these components.[48, 50, 58, 59] Figure 6 reveals 
that the effect of the PMA-IONPs on cell morphology was overall more severe, with the 
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exception of the mNSCs. In the latter, both cell area and circularity were significantly 
affected by the lowest and highest dose of DMSA-IONPs and PMA-IONPs, respectively. 
Likewise, the hNSCs and ReNcells became smaller and more spherical starting from 14 nM 
PMA-IONPs, whereas DMSA-IONPs only significantly altered morphology at 70 nM. Cell 
circularity of the C17.2 cells was not significantly affected but the PMA-IONPs and DMSA-
IONPs did reduce the cell area starting from the lowest and highest dose tested, 
respectively. The cell circularity of the Neuro-2a cells was elevated by both IONPs, while only 
the PMA-IONPs reduced the cell area at higher doses. Finally, since LA-N-2 cells tend to grow 
in clusters, the morphology was analyzed in terms of cluster area and cells per cluster. Here, 
the PMA-IONPs caused a significant concentration dependent decrease in both the average 
cluster area and number of cells per cluster at lower doses compared to the DMSA-IONPs 
(Figure 7). 
 
Discussion  
In this study, we evaluated the extent at which DMSA- and PMA-coated IONPs induced 
adverse effects in six neural cell types, namely NSCs, a progenitor cell line and a cancer cell 
line from murine and human origin. Please note that the same PMA-IONP sample was 
applied as in previous work, where we observed clear dose- and cell type-dependent 
neurotoxicity.[22] The specific aim of this work was to evaluate if such adverse effects could 
be similarly alleviated in the distinct cell types by applying a different coating strategy. The 
cell types were selected based on an important future application of the IONPs, i.e. neural 
cell labeling to allow MRI-guided in vivo cell tracking following transplantation in the context 
of regenerative cell therapy for neural lesions. Multiple studies regarding this topic apply 
various cell models without clearly specifying the species and or cell type (immortalized or 
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cancer cell line, primary cells, stem cells).[26-28] Since NP-evoked effects can differ widely 
amongst various cell models,[33, 35] we evaluated the impact of the cell model on 
nanosafety optimization studies. Hereto, we looked into the impact of both the cell type and 
species in one single study in contrast to previous reports focusing on a single variable.[34, 
37, 38]  
IONP characterization showed that DMSA- and PMA-IONPs had similar basic 
physicochemical properties, in line with previous reports.[22, 25, 39, 60] This was desirable as 
potentially distinct cell responses could be explained in terms of how the cell models 
interact with the NPs, rather than by the intrinsic physicochemical properties of the IONPs. 
Overall, we found the DMSA-IONPs to evoke less extensive responses than the PMA-IONPs. 
In four out of six cell types DMSA-IONPs induced less cytotoxicity than the PMA-IONPs, as 
expected based on recent literature.[23-25] However, the observed toxicity for DMSA-IONPs 
was slightly more severe than anticipated, possibly due to the greater sensitivity of neural 
cells towards NP exposure in general.[16] Cell homeostasis was furthermore perturbed at 
sublethal IONP doses in nearly all combinations tested. In correspondence with previous 
reports, we witnessed unaffected, decreased or induced ROS levels, [55, 61, 62] which was 
more outspoken for the PMA-IONPs. The decreased ROS levels can be explained in terms of 
the intrinsic scavenging potential of intact IONPs or the cellular adaptation to the response 
of foreign materials.[63, 64] The steady state observed for DMSA-IONPs in the cancer cell 
lines can be attributed to the chelating capacity of DMSA, preventing leached iron ions from 
inducing ROS.[14, 23, 25] Still, the DMSA-IONPs were found to significantly induce ROS in the 
hNSCs and ReNcells, possibly indicating that the extent of ion leaching outweighed the 
DMSA chelating capacity or that ROS induction in part occurred through alternate 
mechanisms. Moreover, ROS induction is an acute event depending on the kinetics of NP 
  
14 
 
uptake, intracellular trafficking, the stability of the applied coating and ion leaching.[14, 65] 
Hence, variations in any of these processes could in part explain the distinct responses. 
Finally, variations between human and murine cell types may stem from differences in the 
anti-oxidative capacity, which was reported to be elevated in mice.[66] In addition, the 
DMSA-IONPs most often showed less pronounced responses on the level of the calcium and 
mitochondrial homeostasis and cell morphology. Since all responses can to a certain extent 
be correlated to ROS production,[65, 67] the chelating capacity of DMSA may in part be 
accountable for the improved nanosafety profile. However, additional elements may impact 
the safety profiles. For one, different coating materials will acquire different proteins at their 
surface. This differential protein corona can in turn influence the extent of NP uptake, the 
exploited uptake pathway(s) and subsequent cellular processing.[68] In addition, not all 
coating materials equally protect the IONP surface against the acidic pH and hydrolases in 
the lysosomes.[69] Of note, the coating itself may in turn be sensitive to lysosomal 
degradation and released degradation products can also affect the cell homeostasis.[70] 
Hence, further research will be required to unveil the exact mechanism behind the improved 
biocompatibility of DMSA-IONPs.  
From the multiparametric data set in each cell type alone it would be concluded that the 
DMSA-IONPs are the preferred candidate for further optimization since they generally 
evoked less severe effects, regardless of the distinct culture medium composition for the 
different cell types. The cell media could potentially influence IONP uptake through an 
impact on the colloidal stability and the formation of a protein corona.[71, 72] Such 
variations in IONP uptake could certainly impact the evoked effects, although a linear 
relationship between the intracellular NP dose and the cytotoxicity is not always evident.[35] 
Hence, these parameters were not investigated in detail since we preferentially focused on 
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investigating how various cell models (i.e. the cell type and its optimal medium) respond to 
IONP exposure. Furthermore, adequate IONP uptake and colloidal stability were previously 
documented for the applied coating materials.[24, 47, 73] Nevertheless, further 
characterization of the protein corona and IONP uptake in the applied cell models would 
improve our understanding of the observed adverse events.[74]  
Most importantly, a correct conclusion on the preferable IONP coating for the envisioned 
application could only be reached when a multiparametric approach was applied, as in rare 
cases the DMSA-IONPs more severely perturbed cell homeostasis. Overall, a distinct 
nanotoxicity profile was obtained in each applied cell model. The sensitivity of the cell model 
was furthermore clearly species-related, as human cell types were more sensitive towards 
DMSA-IONP-induced effects. Likewise, Zhang et al. found human macrophages to be more 
sensitive towards DMSA-IONPs than the murine alternative.[75] Secondly, the cell type was 
a major factor since for both the human and murine cell types the NSCs were found to be 
most sensitive towards both IONPs, whereas the cancer cell lines were most resilient. This is 
in agreement with the observation that tumor cells have several characteristics making them 
less prone to NP-induced effects, as cell transformation or immortalization is accompanied 
by phenotypical changes on the level of cell morphology, metabolic rate, proliferation rate, 
etc.[33, 76] Hence, intrinsic variations between cell types can at least in part be held 
accountable for the observed variations, as more elaborately described previously.[77] 
Finally, not all cell models showed a similar sensitivity on all evaluated end points. For 
instance, no significant differences could be detected in IONP-induced mitochondrial 
damage in the cancer cell lines, while this was true for all other cell types. Hence, nanosafety 
screenings to define suitable NPs for a certain application should be performed in a 
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multiparametric fashion evaluating sensitive and informative end points in sufficiently 
sensitive cell types.  
To progress towards a clinical application, we should further investigate whether our cell 
labeling protocol allows sufficient IONP internalization to allow cell detection through MRI, 
as labeling parameters are reported to influence the MRI visibility.[78] IONP-labeled cells can 
generally be detected starting from 10-30 pg iron per cell.[79] However, the MRI signal is 
reported to decrease as a function of time due to IONP dilution through cell division and 
lysosomal degradation of the IONPs.[80-82] Thus, we should evaluate if sufficiently high 
intracellular IONP levels can be safely obtained with the sublethal IONP doses to ensure 
long-term cell tracking. Moreover, further testing would be required to establish the 
importance of the detected adverse events on long-term cell function and rule out delayed 
cytotoxicity, as this was previously observed for the DMSA-IONP labeling of primary 
neurons.[83] Based on our observations we suggest that NSCs are the preferred model for 
further investigation given the selected application. In preference the hNSCs should be 
applied since both NSCs showed opposite effects on the level of ROS and Ca2+ in response to 
DMSA-IONP labeling.  
 
Conclusion 
IONPs are of interest as MRI contrast agents for the labeling of transplanted neural stem 
cells (NSCs), albeit that nanotoxicity remains a concern. Cell-nanoparticle interactions of 
DMSA- and PMA-coated IONPs were investigated in human and murine NSC, neural 
progenitor and neuroblastoma cells. The overall nanosafety profile of the DMSA-IONPs was 
superior compared to the PMA-IONPs. Importantly, a multiparametric approach was 
required to reach this conclusion. In the cell lines we predominantly found both IONPs to 
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evoke similar responses. In contrast, clear interspecies variations were detected on ROS 
production and Ca2+ homeostasis in the NSCs, where both IONPs were found to evoke 
opposite effects. This is an important observation, as the hNSCs are considered to be the 
most representative model for the envisioned application. Thus, the DMSA-coating could not 
in all cell types equally alleviate the induced nanotoxicity compared to the PMA-IONPs. 
Overall, sufficiently sensitive cell lines can be applied when performing a multiparametric 
screening to define suitable candidates for a certain biomedical application. However, 
further thorough safety evaluations should be performed on a non-cancerous human cell 
model most closely resembling the target cell or tissue whenever possible.  
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Figure Captions 
 
Figure 1: DMSA- and PMA-coated IONPs.  
(a) DMSA-IONPs, (b) PMA-IONPs, (c) TEM image (scale bar corresponds to 20 nm) of the bare 
IONPs and (d) the corresponding size distribution histogram of the iron oxide cores N(dc).  
 
Figure 2: Human cell types experience stronger dose dependent cytotoxicity.   
Cytotoxicity as determined with the CellTiter GLO® assay following 24 hours exposure to 
DMSA- (black) and PMA-coated (white) IONPs. Statistical significance with regard to the 
untreated control is indicated when appropriate (* p < 0.05) in black for the DMSA-IONPs 
and grey for the PMA-coated IONPs. (NTC = not treated control) 
  
Figure 3: IONP exposure affects ROS production.  
The influence of 24 hours DMSA-IONP (black bars) and PMA-IONP (white bars) exposure on 
reactive oxygen species (ROS) production as detected with the CellROX® green probe, with 
the latter generally evoking stronger responses. When appropriate, statistical significance 
with respect to the untreated control is indicated in grey for the PMA-IONPs and in black for 
the DMSA-IONPs (* p < 0.05). (NTC = not treated control) 
 
Figure 4: Increased or declined [Ca2+]c by IONPs.  
The cytosolic free calcium concentration ([Ca2+]c) was visualized with Rhod-2 AM following 
24 hours exposure to DMSA-IONPs (black bars) and PMA-IONPs (white bars). Grey and black 
* represent significant alterations when compared to the untreated control (* p < 0.05) 
induced by respectively PMA-IONPs and DMSA-IONPs. (NTC = not treated control) 
 
Figure 5: Mitochondria are more severely affected in the human cell types.  
DMSA-IONP (black bars) and PMA-IONP (white bars) induced effects on mitochondrial 
homeostasis in terms of the relative mitochondrial area as visualized with Mitotracker® 
CMX-ROS. Statistical significance with regard to the untreated control is indicated when 
appropriate (* p < 0.05), in black for significant effects evoked by IONP-DMSA and in gray for 
the PMA-coated IONP. (NTC = not treated control) 
 
Figure 6: DMSA-IONPs have a minor impact on cell morphology.  
The effect on cell morphology of 24 hours exposure to DMSA-IONPs (top row) and PMA-
IONPs (lower row) represented as changes in relative cell area (black bars) and cell circularity 
(blue lines). In general cell circularity is a more sensitive parameter and DMSA-IONPs induce 
least severe effects. Statistical significance with regard to the untreated control is indicated 
when appropriate in the corresponding color, black for cell area and blue for circularity (* p < 
0.05). (NTC = not treated control) 
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Figure 7: LA-N-2 cell morphology is most affected by IONP-PMA exposure.  
The effect of both IONPs on the LA-N-2 cell line in terms of the total cluster area (black bars) 
and cells per cluster (white bars). Grey and black * represent significant alterations when 
compared to the untreated control (* p < 0.05) for respectively cluster area and cells per 
cluster. (NTC = not treated control) 
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Figure 7: LA-N-2 cell morphology is least affected by DMSA-IONP exposure. 
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Graphical abstract 
 
 
Figure 1: DMSA- and PMA-coated IONPs.  
(a) DMSA-IONPs, (b) PMA-IONPs, (c) TEM image (scale bar corresponds to 20 nm) of the bare 
IONPs and (d) the corresponding size distribution histogram of the iron oxide cores N(dc).  
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Figure 2: Human cell types experience stronger dose dependent acute cell damage.   
Cytotoxicity as determined with the CellTiter GLO® assay following 24 hours exposure to 
DMSA- (black) and PMA-coated (white) IONPs. Statistical significance with regard to the 
untreated control is indicated when appropriate (* p < 0.05) in black for the DMSA-IONPs 
and grey for the PMA-coated IONPs. (NTC = not treated control) 
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Figure 3: IONP exposure affects ROS production.  
The influence of 24 hours DMSA-IONP (black bars) and PMA-IONP (white bars) exposure on 
reactive oxygen species (ROS) production as detected with the CellROX® green probe, with 
the latter generally evoking stronger responses. When appropriate, statistical significance 
with respect to the untreated control is indicated in grey for the PMA-IONPs and in black for 
the DMSA-IONPs (* p < 0.05). (NTC = not treated control) 
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Figure 4: Increased or declined [Ca2+]c by IONPs. 
The cytosolic free calcium concentration ([Ca2+]c) was visualized with Rhod-2 AM following 
24 hours exposure to DMSA-IONPs (black bars) and PMA-IONPs (white bars). Grey and black 
* represent significant alterations when compared to the untreated control (* p < 0.05) 
induced by respectively IONP-PMA and DMSA-IONPs. (NTC = not treated control) 
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Figure 5: Mitochondria are more severely affected in the human cell types. 
DMSA-IONP (black bars) and PMA-IONP (white bars) induced effects on mitochondrial 
homeostasis in terms of the relative mitochondrial area as visualized with Mitotracker® 
CMX-ROS. Statistical significance with regard to the untreated control is indicated when 
appropriate (* p < 0.05), in black for significant effects evoked by IONP-DMSA and in gray for 
the PMA-coated IONP. (NTC = not treated control) 
 
 
 
Figure 6: DMSA-IONPs have a minor impact on cell morphology.  
The effect on cell morphology of 24 hours exposure to DMSA-IONPs (top row) and PMA-
IONPs (lower row) represented as changes in relative cell area (black bars) and cell circularity 
  
32 
 
(blue lines). In general cell circularity is a more sensitive parameter and DMSA-IONPs induce 
least severe effects. Statistical significance with regard to the untreated control is indicated 
when appropriate in the corresponding color, black for cell area and blue for circularity (* p < 
0.05). (NTC = not treated control) 
 
 
 
Figure 7: LA-N-2 cell morphology is least affected by DMSA-IONP exposure. 
The effect of both IONPs on the LA-N-2 cell line in terms of the total cluster area (black bars) 
and cells per cluster (white bars). Grey and black * represent significant alterations when 
compared to the untreated control (* p < 0.05) for respectively cluster area and cells per 
cluster. (NTC = not treated control) 
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STATEMENT OF SIGNIFICANCE 
 
Inorganic nanoparticle (NP) optimization is chiefly performed in vitro. For the optimization of 
iron oxide (IO)NPs for neural stem cell labeling in the context of regenerative medicine 
human or rodent neural stem cells, immortalized or cancer cell lines are applied. However, 
the use of certain cell models can be questioned as they phenotypically differ from the 
target cell. The impact of the neural cell model on nanosafety remains relatively unexplored. 
Here we evaluated cell homeostasis upon exposure to PMA- and DMSA-coated IONPs. Of 
note, the DMSA-IONPs outperformed the PMA-IONPs in each cell type. However, distinct cell 
type-specific effects were witnessed indicating that nanosafety should be evaluated in a 
human cell model that represents the target cell as closely as possible.   
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